TY  - JOUR
AU  - Segrelles, Carmen
AU  - Contreras, David
AU  - Navarro, Elena M
AU  - Gutiérrez-Muñoz, Carmen
AU  - García-Escudero, Ramón
AU  - Paramio, Jesús M
AU  - Lorz, Corina
PY  - 2018
DO  - 10.3390/ijms19071824
UR  - https://hdl.handle.net/10668/25469
T2  - International journal of molecular sciences
AB  - Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, and although new therapeutic approaches have been recently evaluated, overall patient survival is still poor. Thus, new effective and selective clinical...
LA  - en
KW  - Alpelisib
KW  - Bosutinib
KW  - EGFR inhibitors
KW  - cancer cell lines
KW  - head and neck cancer
KW  - targeted therapies
KW  - Aniline Compounds
KW  - Animals
KW  - Antineoplastic Agents
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Class I Phosphatidylinositol 3-Kinases
KW  - Drug Combinations
KW  - Drug Synergism
KW  - ErbB Receptors
KW  - Gene Expression Regulation, Neoplastic
KW  - Head and Neck Neoplasms
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Mice
KW  - Mice, Nude
KW  - Nitriles
KW  - Proto-Oncogene Proteins c-abl
KW  - Quinolines
KW  - Signal Transduction
KW  - Thiazoles
KW  - Tumor Burden
KW  - Xenograft Model Antitumor Assays
KW  - src-Family Kinases
TI  - Bosutinib Inhibits EGFR Activation in Head and Neck Cancer.
TY  - research article
VL  - 19
ER  -